Fingerprint
Dive into the research topics of 'High-dose recombinant interleukin-2 alone: A regimen with limited activity in the treatment of advanced renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Jeffrey S. Abrams, Anthony A. Rayner, Peter H. Wiernik, David R. Parkinson, Mario Eisenberger, Frederick R. Aronson, Rasim Gucalp, Michael B. Atkins, Michael J. Hawkins
Research output: Contribution to journal › Article › peer-review